Revenue, 2025
USD 53.69 Bn
Forecast Year, 2034
USD 122.37 Bn
CAGR, 2025 - 2034
8.59%
Report Coverage
Worldwide
The blood plasma derivatives market was valued at USD 53.69 billion in 2025 and is expected to reach nearly USD 122.37 billion by 2034, expanding at a CAGR of 8.59%, driven by rising demand for immunoglobulins and plasma-based therapies.
Blood Plasma Derivatives Market Size Analysis
Blood Plasma Derivatives Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Albumin | 9.66 | 10.48 | 11.36 | 12.32 | 13.35 | 14.48 | 15.70 | 17.02 | 18.45 | 20.00 |
| Factor VIII | 9.13 | 9.92 | 10.77 | 11.70 | 12.71 | 13.81 | 15.00 | 16.30 | 17.70 | 19.23 |
| Factor IX | 6.44 | 6.98 | 7.56 | 8.19 | 8.87 | 9.60 | 10.40 | 11.27 | 12.20 | 13.22 |
| Immunoglobulin | 15.03 | 16.38 | 17.85 | 19.45 | 21.19 | 23.09 | 25.15 | 27.40 | 29.86 | 32.53 |
| Hyperimmune Globulin | 8.05 | 8.74 | 9.49 | 10.29 | 11.17 | 12.13 | 13.16 | 14.28 | 15.50 | 16.82 |
| Others | 5.37 | 5.81 | 6.29 | 6.80 | 7.36 | 7.96 | 8.62 | 9.32 | 10.09 | 10.92 |
Blood Plasma Derivatives Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemophilia | 17.18 | 18.67 | 20.28 | 22.04 | 23.95 | 26.02 | 28.27 | 30.72 | 33.37 | 36.26 |
| Hypogammaglobulinemia | 9.66 | 10.48 | 11.36 | 12.32 | 13.36 | 14.49 | 15.71 | 17.04 | 18.48 | 20.04 |
| Immunodeficiency Diseases | 14.50 | 15.78 | 17.18 | 18.71 | 20.36 | 22.17 | 24.14 | 26.28 | 28.61 | 31.14 |
| Von Willebrand Disease | 6.98 | 7.56 | 8.19 | 8.87 | 9.61 | 10.41 | 11.28 | 12.22 | 13.24 | 14.34 |
| Other | 5.37 | 5.81 | 6.29 | 6.81 | 7.37 | 7.97 | 8.63 | 9.34 | 10.10 | 10.93 |
Blood Plasma Derivatives Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 20.40 | 22.11 | 23.95 | 25.96 | 28.12 | 30.48 | 33.02 | 35.78 | 38.77 | 42.01 |
| Europe | 13.96 | 15.14 | 16.42 | 17.81 | 19.32 | 20.96 | 22.73 | 24.65 | 26.74 | 29.00 |
| Asia Pacific | 11.81 | 12.89 | 14.06 | 15.34 | 16.74 | 18.27 | 19.93 | 21.74 | 23.72 | 25.88 |
| Latin America | 4.30 | 4.67 | 5.07 | 5.51 | 5.99 | 6.51 | 7.08 | 7.69 | 8.36 | 9.08 |
| Middle East and Africa | 3.22 | 3.50 | 3.80 | 4.12 | 4.48 | 4.86 | 5.28 | 5.73 | 6.22 | 6.75 |
Blood Plasma Derivatives Market Size to Attain USD 122.37 Billion by 2034
The blood plasma derivatives market size was estimated at USD 53.69 bn in 2025 and is projected to be worth around USD 122.37 bn by 2034 a CAGR of 8.59%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com